Title: Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease (Background paper)
Subjects: United States, Gaucher's disease, Treatment, Pharmaceutical policy, Orphan drugs, Gaucher disease, Drug therapy, Glucosylceramidase, Therapeutic use, Orphan Drug Production, Economics